Patients should follow a low-salt diet, engage in exercise, and biomarkers (e.g., VEGF gene polymorphisms) should be investigated to predict hypertension risk and guide personalized dosing strategies (Ayala-de Miguel et al., 2024; Ding et al., 2020). The gene discussed is VEGFA; the disease is Hypertension.